Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma-Reference-Cited by-同舟云学术

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma

Published:2023-07-13 Issue:14 Volume:7 Page:3501-3505
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Lin Richard J.¹²³^ORCID,Kim Soo Jung⁴,Brown Samantha⁵^ORCID,Elko Theresa A.¹²,Ruiz Josel D.¹,Hanley Danielle M.¹,Lia Palomba M.²³⁶,Perales Miguel-Angel¹²³^ORCID,Shah Gunjan L.¹²³,Dahi Parastoo B.¹²³,Scordo Michael¹²³,Sauter Craig S.¹²³,Batlevi Connie L.²³⁶^ORCID,Tomas Ana Alarcon¹^ORCID,Shouval Roni¹²³,Lee Nicole¹,Pavkovic Emma A.¹,Engstler Danielle E.¹,Park Jae H.²³,Salles Gilles A.²³⁶^ORCID,Devlin Sean M.³⁵,Korc-Grodzicki Beatriz³⁴,Hamlin Paul A.³⁶^ORCID,Giralt Sergio A.¹²³^ORCID

Affiliation:

1. 1Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY

2. 2Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY

3. 3Weill Cornell Medical College, New York, NY

4. 4Geriatrics Service, Memorial Sloan Kettering Cancer Center, New York, NY

5. 6Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

6. 5Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/7/14/3501/2065260/blooda_adv-2023-010003-main.pdf

Reference25 articles.

1. Chimeric antigen receptor therapy;June;N Engl J Med,2018

2. Advances in management for older adults with hematologic malignancies;Rosko;J Clin Oncol,2021

3. Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma;Neelapu;Blood,2020

4. Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients--a matched control multicenter cohort study;Ram;Haematologica,2022

5. Real-world adverse events associated with CAR T-cell therapy among adults age >/= 65 years;Zettler;J Geriatr Oncol,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of older adults by a geriatric assessment–guided multidisciplinary clinic before CAR T-cell therapy;Blood Advances;2024-07-12

2. Tailoring Therapy in Older Adults With Hematologic Malignancies;American Society of Clinical Oncology Educational Book;2024-06

3. Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy;Transplantation and Cellular Therapy;2024-05

4. Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review;Journal of Geriatric Oncology;2024-04

5. Curative intent therapy for DLBCL in the elderly;Leukemia & Lymphoma;2024-01-11